Mohammed bin Abdulla Al Thani at an altitude of 6,962 m. On 28 August 2012, he climbed Mt. Elbrus the tallest peak in Europe at an altitude of 5,642m in Russia. Al Thani has climbed Mount Kilimanjaro in Tanzania at an altitude of 5,963m twice, on 25 February 2010 and 12 November 2011, respectively. On 25 December 2012, he climbed Vinson Massif, the highest mountain in Antarctica at an altitude of 4,897 m. On 11 October 2012, he summited Mt. Kosciuszko in Australia at an altitude of 2,228 m. Al Thani has also climbed Mont Blanc on 10 September 2011 at an altitude of 4810
MT-45 States the DEA placed MT-45 in Schedule 1 of the Controlled Substance Act. This took effect January 12, 2018. MT-45 MT-45 (IC-6) is an opioid analgesic drug invented in the 1970s by Dainippon Pharmaceutical Co. It is chemically a 1-substituted-4-(1,2-diphenylethyl)piperazine derivative, which is structurally unrelated to most other opioid drugs. Racemic MT-45 has around 80% the potency of morphine, with almost all opioid activity residing in the (S) enantiomer (the opposite stereochemistry from the related drug lefetamine). It has been used as a lead compound from which a large family of potent opioid drugs have been developed, including full agonists,